I.-M. Shih - Concepedia

Concepedia

Author

I.-M. Shih

Johns Hopkins University

Also Known As

I M Shih, I Shih, I-M Shih, I. -M. Shih, I. Shih, I.-M. SHIH, I.-M. Shih, I.M. SHIH, I.M. Shih, I‐M Shih

31

Publications

1.5K

Citations

13

H-Index

36

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine The Wistar Institute Sidney Kimmel Comprehensive Cancer Center

IS

About

I.-M. Shih is an author at Johns Hopkins University specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	946
2	Cell Biology	4	4	873
3	Immunology	3	3	200
4	Pathology	3	3	606
5	Clinical Immunology	1	1	44

I.-M. Shih

×

13

Publications

1.5K

Citations

13

H-Index

	Year	Citations
TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL Hai Yan, Patrick Killela, Zachary J. Reitman, Neuro-Oncology Neuro-oncologyLineage PlasticitySomatic VariantTumor HeterogeneityMedicine	2014	533
NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response Yi Zhang, Yan Cheng, Xuli Ren, Oncogene Hmgb1-mediated Autophagic ResponseOncologyCell RegulationMedicineAutophagy	2011	133
Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity Wang Tl, Morris Ling, I.-M. Shih, Gene Therapy Tumor ImmunologyCancer ImmunosurveillanceImmunologyTumor ImmunityE7-transfected Dendritic Cells	2000	127
Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. I.-M. Shih, David E. Elder, Miao-Ju Hsu, PubMed	1994	125
Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance Ritu Salani, R. J. Kurman, Robert Giuntoli, International Journal of Gynecological Cancer	2007	116
A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue. I.-M. Shih, Mark Nesbit, Meenhard Herlyn, PubMed	1998	96
NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway Natini Jinawath, Chanont Vasoontara, Kai Lee Yap, Oncogene Gadd45 PathwayMedicineCancer BiologyTumor SuppressorCancer Genetics	2009	80
Expression of Mel-CAM in implantation site intermediate trophoblastic cell line, IST-1, limits its migration on uterine smooth muscle cells I.-M. Shih, T.-L. Wang, T.‐C. Wu, Journal of Cell Science	1998	67
Serous borderline tumours of the ovary R. J. Kurman, Jeffrey D. Seidman, I.-M. Shih Histopathology	2005	65
Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma A. Santillan, Y. W. Kim, Mariana L. Zahurak, International Journal of Gynecological Cancer	2007	63

Page 1